PLEURAL THICKENING

This adverse event was reported 684 times

These drugs are most commonly taken by patients reporting PLEURAL THICKENING:

# Drug Count
0 ACETAMINOPHEN 163
1 METHOTREXATE SODIUM 157
2 PREDNISONE 156
3 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 149
4 CELECOXIB 148
5 MOMETASONE FUROATE 138
6 METHOTREXATE 131
7 ETANERCEPT 126
8 GABAPENTIN 125
9 SULFASALAZINE 123
See all common drugs associated with PLEURAL THICKENING

PLEURAL THICKENING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 4% LIDOCAINE 1 0.0303
1 HYPROMELLOSE 2208 (15000 MPA.S) 1 0.0233
2 PERPHENAZINE 37 0.0177
3 PYRIDOXINE HYDROCHLORIDE 30 0.0110
4 NORTRIPTYLINE HYDROCHLORIDE 53 0.0089
5 LEVAMLODIPINE 1 0.0080
6 ILOPROST 6 0.0064
7 DACOMITINIB 4 0.0053
8 TRAZODONE HYDROCHLORIDE 72 0.0046
9 DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 56 0.0041
See all drugs enriched for association with PLEURAL THICKENING

PLEURAL THICKENING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostacycline [EPC] 6 0.0064
1 Provitamin D2 Compound [EPC] 104 0.0035
2 CD123 Interaction [EPC] 1 0.0019
3 Phenothiazine [EPC] 40 0.0013
4 Aminosalicylate [EPC] 125 0.0012
5 Interleukin-6 Receptor Antagonist [EPC] 119 0.0009
6 Selective T Cell Costimulation Modulator [EPC] 118 0.0008
7 Arteriolar Vasodilator [EPC] 66 0.0008
8 Estrogen Receptor Antagonist [EPC] 34 0.0008
9 Lymphocyte Growth Factor [EPC] 1 0.0008
See all drug classes enriched for association with PLEURAL THICKENING